Skip to content

To See effect of Dushtavranaprashaman Lepa in Treatment of Dushta Vrana with reference to Infected Wound

RANDOMIZED CONTROLLED OPEN CLINICAL STUDY TO EVALUATE THE EFFICACY OF DUSHTAVRANPRASHAMAN LEPA IN THE MANAGEMENT OF DUSHTA VRANA W.S.R. TO INFECTED WOUND. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082379
Enrollment
60
Registered
2025-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B968- Other specified bacterial agents as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr.VJD Gramin Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient Having Signs and Symptoms of Dushta Vrana (Infected Wound). 2. Age 20-60 Yrs. 3. Patient of Either Sex Will Be Selected. 4. Dushta Vrana within Size Length Up to 5cm, Depth Up to 0.5 cm. 5. Superficial wound involving only epidermis and dermal papillae.

Exclusion criteria

Exclusion criteria: 1. Patient Suffering from Major Illness Like Cirrhosis, Ascites, Renal failure, DM,TB, Leprosy, Pregnancy, Jaundice, Varicosity, HIV, HBsAg, Malnutrition. 2. Patient With Malignancy. 3. Bleeding Disorder (Increased BT & CT). 4. Complex & Multiple Wound. 5. Diabetic wound. 6. Anaemic Patient Hb less than 9 g/dL. 7. Septicemia And Operative Wounds. 8. Medicolegal Cases.

Design outcomes

Primary

MeasureTime frame
Symptoms Like1)Vedana (Pain) 2)Kandu (Itching) 3)Varna (Color) 4)Gandha (Smell) 5)Strava (Discharge) 6)Slough 7)Granulation TissueTimepoint: 3,5,7,10,15 days

Secondary

MeasureTime frame
Decrease in Overall SymptomsTimepoint: As per Follow up of patient mentioned

Countries

India

Contacts

Public ContactDr Gayatri Mawale

Dr.VJD Gramin Ayurved Mahavidyalaya,Patur

gayatriakola@gmail.com9850500860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026